Use of intravenous cyclophosphamide in vasculitis patients : adherence to local pharmacotherapy management guidelines

Abstract

A poster presentation regarding the use of intravenous cyclophosphamide in vasculitis patients and adherence to local pharmacotherapy management guidelines. Introduction: Intravenous (IV) cyclophosphamide is considered central in the pharmacotherapy management of vasculitis, which if untreated, could lead to multi-organ damage and untimely patients’ death. An evidenced-based shared care guideline (SCG) on the prescribing of IV cyclophosphamide in vasculitis patients is in use at Mater Dei Hospital, Malta. This guideline helps clinicians, pharmacists and nurses to work together as a team towards effective patient safety and increasing the quality of care service offered to patients. Aims: • To assess the clinical adherence to the shared

care guideline on the pharmacotherapy management of intravenous cyclophosphamide in vasculitis patients. • To identify gaps in adherence against the shared care guideline.